$VRSN
VeriSign, Inc

2021 Q4 Form 10-Q Financial Statement

#000101447321000027 Filed on October 28, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q4
Revenue $340.3M $334.2M $320.3M
YoY Change 6.25% 5.15% 3.16%
Cost Of Revenue $49.37M $47.80M $46.00M
YoY Change 7.32% 6.17% -1.08%
Gross Profit $290.9M $286.4M $274.3M
YoY Change 6.07% 4.98% 3.86%
Gross Profit Margin 85.49% 85.7% 85.64%
Selling, General & Admin $47.98M $45.57M $50.40M
YoY Change -4.79% -2.0% 0.0%
% of Gross Profit 16.49% 15.91% 18.37%
Research & Development $20.84M $19.57M $19.40M
YoY Change 7.44% -0.72% 28.48%
% of Gross Profit 7.16% 6.83% 7.07%
Depreciation & Amortization $12.33M $12.03M $11.90M
YoY Change 3.62% 2.84% -0.83%
% of Gross Profit 4.24% 4.2% 4.34%
Operating Expenses $68.83M $65.14M $69.80M
YoY Change -1.39% -1.62% 6.56%
Operating Profit $222.1M $221.3M $204.5M
YoY Change 8.61% 7.09% 2.97%
Interest Expense -$18.68M $18.83M -$22.20M
YoY Change -15.84% -16.45% 29.07%
% of Operating Profit -8.41% 8.51% -10.86%
Other Income/Expense, Net -$40.00K $164.0K -$200.0K
YoY Change -80.0% -78.84% -107.14%
Pretax Income $203.4M $202.6M $182.9M
YoY Change 11.2% 9.6% -1.14%
Income Tax -$126.7M $46.02M $25.60M
% Of Pretax Income -62.29% 22.71% 14.0%
Net Earnings $330.1M $156.6M $157.3M
YoY Change 109.84% -8.4% 6.07%
Net Earnings / Revenue 97.0% 46.86% 49.11%
Basic Earnings Per Share
Diluted Earnings Per Share $2.972M $1.401M $1.379M
COMMON SHARES
Basic Shares Outstanding 111.1M shares 111.7M shares 114.1M shares
Diluted Shares Outstanding 111.8M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.206B $1.198B $1.167B
YoY Change 3.33% 4.21% -4.19%
Cash & Equivalents $223.5M $256.9M $401.2M
Short-Term Investments $982.3M $941.6M $766.0M
Other Short-Term Assets $62.90M $65.99M $2.245M
YoY Change 2701.78% 18.33% 36.97%
Inventory
Prepaid Expenses $24.80M $31.19M $17.92M
Receivables $5.300M $5.062M $4.642M
Other Receivables $7.669M $4.091M $0.00
Total Short-Term Assets $1.269B $1.264B $1.218B
YoY Change 4.17% 4.83% -4.74%
LONG-TERM ASSETS
Property, Plant & Equipment $251.2M $249.1M $245.6M
YoY Change 2.29% 0.2% -1.88%
Goodwill $52.50M $52.53M $52.53M
YoY Change -0.05% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $35.70M $38.51M $37.96M
YoY Change -5.95% 9.53% -4.66%
Total Long-Term Assets $715.1M $550.3M $549.0M
YoY Change 30.26% -1.41% -4.6%
TOTAL ASSETS
Total Short-Term Assets $1.269B $1.264B $1.218B
Total Long-Term Assets $715.1M $550.3M $549.0M
Total Assets $1.984B $1.815B $1.767B
YoY Change 12.28% 2.86% -4.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.997M $6.233M $12.00M
YoY Change -25.03% -37.67% -25.0%
Accrued Expenses $100.2M $98.83M $103.0M
YoY Change -2.75% 2.94% 6.19%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.074B $1.048B $988.7M
YoY Change 8.63% 7.17% 2.44%
LONG-TERM LIABILITIES
Long-Term Debt $1.786B $1.785B $1.790B
YoY Change -0.24% -0.22% 0.11%
Other Long-Term Liabilities $78.60M $84.87M $95.49M
YoY Change -17.69% -16.14% -69.46%
Total Long-Term Liabilities $2.170B $2.184B $2.168B
YoY Change 0.09% 0.53% -8.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.074B $1.048B $988.7M
Total Long-Term Liabilities $2.170B $2.184B $2.168B
Total Liabilities $3.244B $3.232B $3.157B
YoY Change 2.76% 2.59% -5.59%
SHAREHOLDERS EQUITY
Retained Earnings -$14.88B -$15.21B -$15.66B
YoY Change -5.01% -3.87% -4.95%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $11.52B
YoY Change 6.57%
Treasury Stock Shares 242.9M shares
Shareholders Equity -$1.261B -$1.418B -$1.390B
YoY Change
Total Liabilities & Shareholders Equity $1.984B $1.815B $1.767B
YoY Change 12.28% 2.86% -4.7%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q4
OPERATING ACTIVITIES
Net Income $330.1M $156.6M $157.3M
YoY Change 109.84% -8.4% 6.07%
Depreciation, Depletion And Amortization $12.33M $12.03M $11.90M
YoY Change 3.62% 2.84% -0.83%
Cash From Operating Activities $206.2M $260.1M $195.2M
YoY Change 5.66% 86.29% 0.83%
INVESTING ACTIVITIES
Capital Expenditures -$13.50M -$15.27M -$6.500M
YoY Change 107.65% 1.77% -26.14%
Acquisitions
YoY Change
Other Investing Activities -$40.66M -$34.94M $240.0M
YoY Change -116.94% -69.98% -42.0%
Cash From Investing Activities -$54.15M -$50.21M $233.5M
YoY Change -123.19% -61.79% -42.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -185.8M -172.5M -173.8M
YoY Change 6.91% 1.74% -13.1%
NET CHANGE
Cash From Operating Activities 206.2M 260.1M 195.2M
Cash From Investing Activities -54.15M -50.21M 233.5M
Cash From Financing Activities -185.8M -172.5M -173.8M
Net Change In Cash -33.72M 37.31M 254.9M
YoY Change -113.23% -123.11% -36.05%
FREE CASH FLOW
Cash From Operating Activities $206.2M $260.1M $195.2M
Capital Expenditures -$13.50M -$15.27M -$6.500M
Free Cash Flow $219.7M $275.3M $201.7M
YoY Change 8.94% 78.09% -0.35%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
VERISIGN INC/CA
dei Entity Central Index Key
EntityCentralIndexKey
0001014473
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-23593
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3221585
dei Entity Address Address Line1
EntityAddressAddressLine1
12061 Bluemont Way,
dei Entity Address City Or Town
EntityAddressCityOrTown
Reston,
dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20190
dei City Area Code
CityAreaCode
703
dei Local Phone Number
LocalPhoneNumber
948-3200
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
VRSN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Shell Company
EntityShellCompany
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
111078436 shares
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
256869000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
401194000 USD
CY2021Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
941552000 USD
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
765713000 USD
CY2021Q3 us-gaap Other Assets Current
OtherAssetsCurrent
65989000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
51033000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
1264410000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1217940000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
249093000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
245571000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
52527000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
52527000 USD
CY2021Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
65163000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
67914000 USD
CY2021Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
145000000 USD
CY2020Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
145000000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
38514000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
37958000 USD
CY2021Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
550297000 USD
CY2020Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
548970000 USD
CY2021Q3 us-gaap Assets
Assets
1814707000 USD
CY2020Q4 us-gaap Assets
Assets
1766910000 USD
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
204511000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
208642000 USD
CY2021Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
843664000 USD
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
780051000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1048175000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
988693000 USD
CY2021Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
314089000 USD
CY2020Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
282838000 USD
CY2021Q3 us-gaap Senior Long Term Notes
SeniorLongTermNotes
1785152000 USD
CY2020Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
1790083000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
84869000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
95494000 USD
CY2021Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2184110000 USD
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2168415000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
3232285000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
3157108000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
354154000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
353789000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
111283000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
113470000 shares
CY2021Q3 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
13793049000 USD
CY2020Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
14275160000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15207854000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15662602000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2773000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2756000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-1417578000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1390198000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1814707000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1766910000 USD
CY2021Q3 us-gaap Revenues
Revenues
334242000 USD
CY2020Q3 us-gaap Revenues
Revenues
317879000 USD
us-gaap Revenues
Revenues
987268000 USD
us-gaap Revenues
Revenues
944768000 USD
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
47801000 USD
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
45024000 USD
us-gaap Cost Of Revenue
CostOfRevenue
142565000 USD
us-gaap Cost Of Revenue
CostOfRevenue
134205000 USD
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9410000 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8389000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
28115000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
23883000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19566000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19708000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
59685000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
55268000 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
36160000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38109000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
112212000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
111719000 USD
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
112937000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
111230000 USD
us-gaap Costs And Expenses
CostsAndExpenses
342577000 USD
us-gaap Costs And Expenses
CostsAndExpenses
325075000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
221305000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
206649000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
644691000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
619693000 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
18829000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
22537000 USD
us-gaap Interest Expense
InterestExpense
64427000 USD
us-gaap Interest Expense
InterestExpense
67607000 USD
CY2021Q3 us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
164000 USD
CY2020Q3 us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
775000 USD
us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
-1433000 USD
us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
15262000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
202640000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
184887000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
578831000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
567348000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
46018000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13908000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
124083000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-90226000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
156622000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
170979000 USD
us-gaap Net Income Loss
NetIncomeLoss
454748000 USD
us-gaap Net Income Loss
NetIncomeLoss
657574000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
61000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-383000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-17000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-120000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
156683000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
170596000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
454731000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
657454000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.40
CY2020Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.49
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
4.05
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
5.70
CY2021Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.40
CY2020Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.49
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
4.04
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
5.68
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
111664000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114655000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
112389000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115456000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
111793000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114831000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
112530000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115699000 shares
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-1417785000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-1400324000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1390198000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-1490100000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-1417578000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-1386248000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-1417578000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-1386248000 USD
us-gaap Profit Loss
ProfitLoss
454748000 USD
us-gaap Profit Loss
ProfitLoss
657574000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
35609000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
34463000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
41019000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
36106000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-5410000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
8482000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
19735000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
11107000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5529000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5912000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
94863000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
27673000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
5476000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
195353000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
600909000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
534962000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
2246148000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
1804541000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
2421705000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
2093437000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
39536000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36933000 USD
us-gaap Payments For Proceeds From Businesses And Interest In Affiliates
PaymentsForProceedsFromBusinessesAndInterestInAffiliates
0 USD
us-gaap Payments For Proceeds From Businesses And Interest In Affiliates
PaymentsForProceedsFromBusinessesAndInterestInAffiliates
-20009000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-215093000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-305820000 USD
us-gaap Repayments Of Debt Maturing In More Than Three Months
RepaymentsOfDebtMaturingInMoreThanThreeMonths
750000000 USD
us-gaap Repayments Of Debt Maturing In More Than Three Months
RepaymentsOfDebtMaturingInMoreThanThreeMonths
0 USD
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
741075000 USD
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
536797000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
603705000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
12404000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
12577000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-533318000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-591128000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-600000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-506000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-148102000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-362492000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
410601000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
517601000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
262499000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
155109000 USD
us-gaap Interest Paid Net
InterestPaidNet
61845000 USD
us-gaap Interest Paid Net
InterestPaidNet
56860000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
132202000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
105258000 USD
CY2021Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
24317000 USD
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
28832000 USD
CY2021Q3 us-gaap Time Deposits At Carrying Value
TimeDepositsAtCarryingValue
3708000 USD
CY2020Q4 us-gaap Time Deposits At Carrying Value
TimeDepositsAtCarryingValue
4176000 USD
CY2021Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
208377000 USD
CY2020Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
129627000 USD
CY2021Q3 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
967649000 USD
CY2020Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
1013679000 USD
CY2021Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
1204051000 USD
CY2020Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
1176314000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
256869000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
401194000 USD
CY2021Q3 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
5630000 USD
CY2020Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
9407000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
262499000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
410601000 USD
CY2021Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
941552000 USD
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
765713000 USD
CY2021Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
1204051000 USD
CY2020Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
1176314000 USD
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
100000 USD
CY2021Q3 vrsn Debtinstrumentfairvalueseniornotes2025
Debtinstrumentfairvalueseniornotes2025
563600000 USD
CY2021Q3 vrsn Debt Instrument Fair Value Senior Notes2027
DebtInstrumentFairValueSeniorNotes2027
580000000 USD
CY2021Q3 vrsn Debt Instrument Fair Value Senior Notes2031
DebtInstrumentFairValueSeniorNotes2031
763500000 USD
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
31189000 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
17920000 USD
CY2021Q3 vrsn Prepaidregistryfeescurrent
Prepaidregistryfeescurrent
24513000 USD
CY2020Q4 vrsn Prepaidregistryfeescurrent
Prepaidregistryfeescurrent
22654000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5062000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4642000 USD
CY2021Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4091000 USD
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
3572000 USD
CY2021Q3 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
1134000 USD
CY2020Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
2245000 USD
CY2021Q3 us-gaap Other Assets Current
OtherAssetsCurrent
65989000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
51033000 USD
CY2021Q3 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
12250000 USD
CY2020Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
7105000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9625000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11277000 USD
CY2021Q3 vrsn Prepaidregistryfeesnoncurent
Prepaidregistryfeesnoncurent
8990000 USD
CY2020Q4 vrsn Prepaidregistryfeesnoncurent
Prepaidregistryfeesnoncurent
7997000 USD
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
5630000 USD
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
9407000 USD
CY2021Q3 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
2019000 USD
CY2020Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
2172000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
38514000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
37958000 USD
CY2021Q3 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
9700000 USD
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
28500000 USD
CY2021Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
6233000 USD
CY2020Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
12340000 USD
CY2021Q3 us-gaap Customer Deposits Current
CustomerDepositsCurrent
64650000 USD
CY2020Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
53631000 USD
CY2021Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
48890000 USD
CY2020Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
54596000 USD
CY2021Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
24988000 USD
CY2020Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
24408000 USD
CY2021Q3 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
24593000 USD
CY2020Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
27194000 USD
CY2021Q3 vrsn Accruedfees
Accruedfees
14717000 USD
CY2020Q4 vrsn Accruedfees
Accruedfees
13090000 USD
CY2021Q3 vrsn Customer Incentives Payable
CustomerIncentivesPayable
10210000 USD
CY2020Q4 vrsn Customer Incentives Payable
CustomerIncentivesPayable
12556000 USD
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
10230000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
10827000 USD
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
204511000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
208642000 USD
CY2021Q3 vrsn Other Tax Liabilities Noncurrent
OtherTaxLiabilitiesNoncurrent
82108000 USD
CY2020Q4 vrsn Other Tax Liabilities Noncurrent
OtherTaxLiabilitiesNoncurrent
90335000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2761000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5159000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
84869000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
95494000 USD
CY2021Q3 us-gaap Tax Cuts And Jobs Act Of2017 Transition Tax For Accumulated Foreign Earnings Liability Current
TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityCurrent
7700000 USD
vrsn Additionalsharerepurchaseamountauthorized
Additionalsharerepurchaseamountauthorized
747000000 USD
CY2021Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
253000000 USD
CY2021Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
565100000 USD
CY2021Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
242900000 shares
CY2021Q3 us-gaap Treasury Stock Value
TreasuryStockValue
11520000000 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
111664000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114655000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
112389000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115456000 shares
CY2021Q3 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
129000 shares
CY2020Q3 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
176000 shares
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
141000 shares
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
243000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
111793000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114831000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
112530000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115699000 shares
CY2021Q3 us-gaap Revenues
Revenues
334242000 USD
CY2020Q3 us-gaap Revenues
Revenues
317879000 USD
us-gaap Revenues
Revenues
987268000 USD
us-gaap Revenues
Revenues
944768000 USD
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
665100000 USD
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
14428000 USD
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
12678000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
41019000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
36106000 USD
CY2021Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
391000 USD
CY2020Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
400000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1263000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1420000 USD
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
14428000 USD
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
12678000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
41019000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
36106000 USD
CY2021Q3 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
111000 USD
CY2020Q3 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
805000 USD
us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
438000 USD
us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
7500000 USD
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2149000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q3 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
CY2020Q3 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-9000 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
5602000 USD
CY2021Q3 vrsn Incomefromtransitionservices
Incomefromtransitionservices
0 USD
CY2020Q3 vrsn Incomefromtransitionservices
Incomefromtransitionservices
0 USD
vrsn Incomefromtransitionservices
Incomefromtransitionservices
0 USD
vrsn Incomefromtransitionservices
Incomefromtransitionservices
2100000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
53000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-21000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
278000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
60000 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
164000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
775000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1433000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
15262000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
46018000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13908000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
124083000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-90226000 USD
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.23 Rate
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.08 Rate
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 Rate
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.16 Rate
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 Rate
CY2020Q3 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
24000000 USD
us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
191800000 USD

Files In Submission

Name View Source Status
0001014473-21-000027-index-headers.html Edgar Link pending
0001014473-21-000027-index.html Edgar Link pending
0001014473-21-000027.txt Edgar Link pending
0001014473-21-000027-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vrsn-20210930.htm Edgar Link pending
vrsn-20210930.xsd Edgar Link pending
vrsn-20210930_cal.xml Edgar Link unprocessable
vrsn-20210930_def.xml Edgar Link unprocessable
vrsn-20210930_htm.xml Edgar Link completed
vrsn-20210930_lab.xml Edgar Link unprocessable
vrsn-20210930_pre.xml Edgar Link unprocessable
vrsn-2021930x10qxex3101.htm Edgar Link pending
vrsn-2021930x10qxex3102.htm Edgar Link pending
vrsn-2021930x10qxex3201.htm Edgar Link pending
vrsn-2021930x10qxex3202.htm Edgar Link pending